Absence of large intragenic rearrangements in the DPYD gene in a large cohort of colorectal cancer patients treated with 5-FU-based chemotherapy

af Paré, Laia, Paez, David, Salazar, Juliana, del Rio, Elisabeth, Tizzano, Eduardo, Marcuello, Eugenio, Baiget, Montserrat
Udgivet 2010

Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer

af Gendoo, Deena M. A., Ratanasirigulchai, Natchar, Schröder, Markus S., Paré, Laia, Parker, Joel S., Prat, Aleix, Haibe-Kains, Benjamin
Udgivet i Bioinformatics (2016)

Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE(2) in colorectal cancer

af Cebola, Inês, Custodio, Joaquin, Muñoz, Mar, Díez-Villanueva, Anna, Paré, Laia, Prieto, Patricia, Aussó, Susanna, Coll-Mulet, Llorenç, Boscá, Lisardo, Moreno, Victor, Peinado, Miguel A.
Udgivet i Clin Epigenetics (2015)

Correlative Biomarker Analysis of Intrinsic Subtypes and Efficacy Across the MONALEESA Phase III Studies

af Prat, Aleix, Chaudhury, Anwesha, Solovieff, Nadia, Paré, Laia, Martinez, Débora, Chic, Nuria, Martínez-Sáez, Olga, Brasó-Maristany, Fara, Lteif, Agnes, Taran, Tetiana, Babbar, Naveen, Su, Fei
Udgivet i J Clin Oncol (2021)

Everolimus plus Exemestane for Hormone Receptor‐Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO‐2

af Prat, Aleix, Brase, Jan Christoph, Cheng, Yuan, Nuciforo, Paolo, Paré, Laia, Pascual, Tomás, Martínez, Débora, Galván, Patricia, Vidal, Maria, Adamo, Barbara, Hortobagyi, Gabriel N., Baselga, José, Ciruelos, Eva
Udgivet i Oncologist (2019)

Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®

af Buus, Richard, Szijgyarto, Zsolt, Schuster, Eugene F., Xiao, Hui, Haynes, Ben P., Sestak, Ivana, Cuzick, Jack, Paré, Laia, Seguí, Elia, Chic, Nuria, Prat, Aleix, Dowsett, Mitch, Cheang, Maggie Chon U.
Udgivet i NPJ Breast Cancer (2021)

Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy

af Prat, Aleix, Fan, Cheng, Fernández, Aranzazu, Hoadley, Katherine A., Martinello, Rossella, Vidal, Maria, Viladot, Margarita, Pineda, Estela, Arance, Ana, Muñoz, Montserrat, Paré, Laia, Cheang, Maggie C. U., Adamo, Barbara, Perou, Charles M.
Udgivet i BMC Med (2015)

Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer

af Griguolo, Gaia, Dieci, Maria Vittoria, Paré, Laia, Miglietta, Federica, Generali, Daniele Giulio, Frassoldati, Antonio, Cavanna, Luigi, Bisagni, Giancarlo, Piacentini, Federico, Tagliafico, Enrico, Cagossi, Katia, Ficarra, Guido, Prat, Aleix, Conte, Pierfranco, Guarneri, Valentina
Udgivet i NPJ Breast Cancer (2021)

The altered transcriptome and DNA methylation profiles of docetaxel resistance in breast cancer PDX models

af Gómez-Miragaya, Jorge, Morán, Sebastián, Calleja-Cervantes, Maria Eréndira, Collado-Sole, Alejandro, Paré, Laia, Gómez, Antonio, Serra, Violeta, Dobrolecki, Lacey E., Lewis, Michael T, Diaz-Lagares, Angel, Eroles, Pilar, Prat, Aleix, Esteller, Manel, González-Suárez, Eva
Udgivet i Mol Cancer Res (2019)

PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution

af Pernas, Sonia, Petit, Anna, Climent, Fina, Paré, Laia, Perez-Martin, J., Ventura, Luz, Bergamino, Milana, Galván, Patricia, Falo, Catalina, Morilla, Idoia, Fernandez-Ortega, Adela, Stradella, Agostina, Rey, Montse, Garcia-Tejedor, Amparo, Gil-Gil, Miguel, Prat, Aleix
Udgivet i Front Oncol (2019)

Corrigendum: PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single...

af Pernas, Sonia, Petit, Anna, Climent, Fina, Paré, Laia, Perez-Martin, J., Ventura, Luz, Bergamino, Milana, Galván, Patricia, Falo, Catalina, Morilla, Idoia, Fernandez-Ortega, Adela, Stradella, Agostina, Rey, Montse, Garcia-Tejedor, Amparo, Gil-Gil, Miguel, Prat, Aleix
Udgivet i Front Oncol (2019)

STEM-08 INHIBITION OF THE NEURAL STEM CELL/OLIGODENDROCYTE PROGENITOR FACTOR GPR56 PROMOTES THE PRONEURAL TO MESENCHYMAL TRANSITION AND RADIORESISTANCE IN GLIOBLASTOMA

af Moreno, Marta, Pineda, Estela, Martínez, Josefina, Bejarano, Leire, Balasubramaniyan, Veerakumar, Ezhilarasan, Ravesanker, Kallarackal, Naveen, Kim, Sung-Hak, Paré, Laia, Tortosa, Avelina, Gómez-Manzano, Candelaria, Graus, Francesc, Sulman, Erik, Piao, Xianhua, Nakano, Ichiro, Prat, Aleix, Bhat, Krishna, de la Iglesia, Nuria
Udgivet i Neuro Oncol (2015)

Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial

af Adamo, Barbara, Bellet, Meritxell, Paré, Laia, Pascual, Tomás, Vidal, Maria, Pérez Fidalgo, José A., Blanch, Salvador, Martinez, Noelia, Murillo, Laura, Gómez-Pardo, Patricia, López-González, Ana, Amillano, Kepa, Canes, Jordi, Galván, Patricia, González-Farré, Blanca, González, Xavier, Villagrasa, Patricia, Ciruelos, Eva, Prat, Aleix
Udgivet i Breast Cancer Res (2019)

Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opt...

af Gavilá, Joaquín, Oliveira, Mafalda, Pascual, Tomás, Perez-Garcia, Jose, Gonzàlez, Xavier, Canes, Jordi, Paré, Laia, Calvo, Isabel, Ciruelos, Eva, Muñoz, Montserrat, Virizuela, Juan A., Ruiz, Isabel, Andrés, Raquel, Perelló, Antonia, Martínez, Jerónimo, Morales, Serafín, Marín-Aguilera, Mercedes, Martínez, Débora, Quero, Juan C., Llombart-Cussac, Antonio, Prat, Aleix
Udgivet i BMC Med (2019)

The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers

af De Mattos-Arruda, Leticia, Cortes, Javier, Blanco-Heredia, Juan, Tiezzi, Daniel G., Villacampa, Guillermo, Gonçalves-Ribeiro, Samuel, Paré, Laia, Souza, Carla Anjos, Ortega, Vanesa, Sammut, Stephen-John, Cusco, Pol, Fasani, Roberta, Chin, Suet-Feung, Perez-Garcia, Jose, Dienstmann, Rodrigo, Nuciforo, Paolo, Villagrasa, Patricia, Rubio, Isabel T., Prat, Aleix, Caldas, Carlos
Udgivet i NPJ Breast Cancer (2021)

Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population

af Gómez-Miragaya, Jorge, Palafox, Marta, Paré, Laia, Yoldi, Guillermo, Ferrer, Irene, Vila, Sergi, Galván, Patricia, Pellegrini, Pasquale, Pérez-Montoyo, Hector, Igea, Ana, Muñoz, Purificación, Esteller, Manel, Nebreda, Angel R., Urruticoechea, Ander, Morilla, Idoia, Pernas, Sonia, Climent, Fina, Soler-Monso, María Teresa, Petit, Ana, Serra, Violeta, Prat, Aleix, González-Suárez, Eva
Udgivet i Stem Cell Reports (2017)

Independent validation of the PAM50-based Chemo-Endocrine Score (CES) in hormonal receptor positive HER2-positive breast cancer treated with neoadjuvant anti-HER2-based therapy

af Pascual, Tomás, Fernandez-Martinez, Aranzazu, Tanioka, Maki, Dieci, M. Vittoria, Pernas, Sonia, Gavila, Joaquin, Guarnieri, Valentina, Cortes, Javier, Villagrasa, Patricia, Chic, Núria, Vidal, Maria, Adamo, Barbara, Muñoz, Montserrat, Griguolo, Gaia, Llombart, Antonio, Conte, Pierfranco, Oliveira, Mafalda, Conte, Benedetta, Paré, Laia, Galvan, Patricia, Carey, Lisa A., Perou, Charles M., Prat, Aleix
Udgivet i Clin Cancer Res (2021)

A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer

af Pascual, Tomás, Martin, Miguel, Fernández-Martínez, Aranzazu, Paré, Laia, Alba, Emilio, Rodríguez-Lescure, Álvaro, Perrone, Giuseppe, Cortés, Javier, Morales, Serafín, Lluch, Ana, Urruticoechea, Ander, González-Farré, Blanca, Galván, Patricia, Jares, Pedro, Rodriguez, Adela, Chic, Nuria, Righi, Daniela, Cejalvo, Juan Miguel, Tonini, Giuseppe, Adamo, Barbara, Vidal, Maria, Villagrasa, Patricia, Muñoz, Montserrat, Prat, Aleix
Udgivet i Front Oncol (2019)

Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade

af Brasó-Maristany, Fara, Griguolo, Gaia, Pascual, Tomás, Paré, Laia, Nuciforo, Paolo, Llombart-Cussac, Antonio, Bermejo, Begoña, Oliveira, Mafalda, Morales, Serafín, Martínez, Noelia, Vidal, Maria, Adamo, Barbara, Martínez, Olga, Pernas, Sonia, López, Rafael, Muñoz, Montserrat, Chic, Núria, Galván, Patricia, Garau, Isabel, Manso, Luis, Alarcón, Jesús, Martínez, Eduardo, Gregorio, Sara, Gomis, Roger R., Villagrasa, Patricia, Cortés, Javier, Ciruelos, Eva, Prat, Aleix
Udgivet i Nat Commun (2020)

Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer

af Garrido-Castro, Ana C., Saura, Cristina, Barroso-Sousa, Romualdo, Guo, Hao, Ciruelos, Eva, Bermejo, Begoña, Gavilá, Joaquin, Serra, Violeta, Prat, Aleix, Paré, Laia, Céliz, Pamela, Villagrasa, Patricia, Li, Yisheng, Savoie, Jennifer, Xu, Zhan, Arteaga, Carlos L., Krop, Ian E., Solit, David B., Mills, Gordon B., Cantley, Lewis C., Winer, Eric P., Lin, Nancy U., Rodon, Jordi
Udgivet i Breast Cancer Res (2020)